Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
JAMA Surgery
|
April 27, 2017
A More Common Massive Retroperitoneal Mass
Brock O'Neil, Benjamin Maughan
Urology Case Reports
|
August 9, 2024
Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report
Jackson Howell, Benjamin Maughan, Mark Fluchel, et al.
Case Reports in Medicine
|
July 25, 2014
Primary small cell neuroendocrine carcinoma of paranasal sinuses
Maliha Khan, Sobia Nizami, Aibek E Mirrakhimov, et al.
Clinical Genitourinary Cancer
|
September 30, 2017
Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer
Austin Poole, David Gill, Andrew W Hahn, et al.
The Prostate
|
February 7, 2020
What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing
Samantha Greenberg, Stacey Slager, Brock O' Neil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2025
A Phase 2 Trial of Radium<sup>223</sup> and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR Study
Jonathan Tward, Shane Lloyd, Skyler Johnson, et al.
Oncotarget
|
April 22, 2017
Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications
Andrew W Hahn, David M Gill, Benjamin Maughan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 25, 2017
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors
Erin B Bailey, Joseph Merriman, Benjamin Maughan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2026
Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trial
Ziao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2021
Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer
Sophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
JAMA Surgery
|
April 27, 2017
A More Common Massive Retroperitoneal Mass
Brock O'Neil, Benjamin Maughan
Urology Case Reports
|
August 9, 2024
Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report
Jackson Howell, Benjamin Maughan, Mark Fluchel, et al.
Case Reports in Medicine
|
July 25, 2014
Primary small cell neuroendocrine carcinoma of paranasal sinuses
Maliha Khan, Sobia Nizami, Aibek E Mirrakhimov, et al.
Clinical Genitourinary Cancer
|
September 30, 2017
Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer
Austin Poole, David Gill, Andrew W Hahn, et al.
The Prostate
|
February 7, 2020
What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing
Samantha Greenberg, Stacey Slager, Brock O' Neil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2025
A Phase 2 Trial of Radium<sup>223</sup> and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR Study
Jonathan Tward, Shane Lloyd, Skyler Johnson, et al.
Oncotarget
|
April 22, 2017
Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications
Andrew W Hahn, David M Gill, Benjamin Maughan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 25, 2017
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors
Erin B Bailey, Joseph Merriman, Benjamin Maughan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2026
Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trial
Ziao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2021
Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer
Sophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Page
of 2